CMA drops probe into Merck’s Remicade discounts
The UK’s antitrust enforcer has closed its abuse of dominance investigation into Merck Sharp & Dohme’s discount scheme, despite finding no “procompetitive rationale or efficiency justification” for the conduct.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10